BACKGROUND: β-amyloid (Aβ) plaques in brain's grey matter (GM) are one of the pathological hallmarks of Alzheimer's disease (AD), and can be imaged in vivo using Positron Emission Tomography (PET) with (11)C or (18)F radiotracers. Estimating Aβ burden in cortical GM has been shown to improve diagnosis and monitoring of AD. However, lacking structural information in PET images requires such assessments to be performed with anatomical MRI scans, which may not be available at different clinical settings or being contraindicated for particular reasons. This study aimed to develop an MR-less Aβ imaging quantification method that requires only PET images for reliable Aβ burden estimations. MATERIALS AND METHODS: The proposed method has been devel...
Background: Amyloid PET plays a vital role in detecting the accumulation of in vivo amyloid-β (Aβ). ...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
<div><p>Background</p><p>β-amyloid (Aβ) plaques in brain's grey matter (GM) are one of the pathologi...
Background: b-amyloid (Ab) plaques in brain’s grey matter (GM) are one of the pathological hallmarks...
F radiotracers. Estimating Aβ burden in cortical GM has been shown to improve diagnosis and monitori...
For clinical evaluation, assessing amyloid deposition with PiB-PET is desirable without requiring MR...
(11)C-Pittsburgh compound B (PiB) is a positron emission tomography (PET) tracer designed to bind to...
11C-Pittsburgh compound B (PiB) is a positron emission tomography (PET) tracer designed to bind to a...
The aim of this work was to identify optimal methodological techniques for quantifying 11C-‐Pittsbu...
Background: Quantitative evaluation of amyloid positron emission tomography(PET) with standardized u...
<p>The aim of this work was to identify optimal methodological techniques for quantifying 11C-‐Pitt...
Positron emission tomography (PET) allows for in vivo visualisation and quantification of amyloid-β ...
Objectives:Amyloid PET quantification can be affected by differences in image processing. For exampl...
Objective: Although beta-amyloid (Aβ) positron emission tomography (PET) images are interpreted visu...
Background: Amyloid PET plays a vital role in detecting the accumulation of in vivo amyloid-β (Aβ). ...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
<div><p>Background</p><p>β-amyloid (Aβ) plaques in brain's grey matter (GM) are one of the pathologi...
Background: b-amyloid (Ab) plaques in brain’s grey matter (GM) are one of the pathological hallmarks...
F radiotracers. Estimating Aβ burden in cortical GM has been shown to improve diagnosis and monitori...
For clinical evaluation, assessing amyloid deposition with PiB-PET is desirable without requiring MR...
(11)C-Pittsburgh compound B (PiB) is a positron emission tomography (PET) tracer designed to bind to...
11C-Pittsburgh compound B (PiB) is a positron emission tomography (PET) tracer designed to bind to a...
The aim of this work was to identify optimal methodological techniques for quantifying 11C-‐Pittsbu...
Background: Quantitative evaluation of amyloid positron emission tomography(PET) with standardized u...
<p>The aim of this work was to identify optimal methodological techniques for quantifying 11C-‐Pitt...
Positron emission tomography (PET) allows for in vivo visualisation and quantification of amyloid-β ...
Objectives:Amyloid PET quantification can be affected by differences in image processing. For exampl...
Objective: Although beta-amyloid (Aβ) positron emission tomography (PET) images are interpreted visu...
Background: Amyloid PET plays a vital role in detecting the accumulation of in vivo amyloid-β (Aβ). ...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...